Literature DB >> 30229645

Comparison of culture, microscopic smear and molecular methods in diagnosis of tuberculosis.

I Afsar1, M Gunes, H Er, A Gamze Sener.   

Abstract

OBJECTIVE: Tuberculosis (TB) is a public health problem worldwide, with the highest mortality . The development of nucleic acid-based tests for detection of Mycobacterium tuberculosis complex (MTBC) has significantly increased sensitivity compared to conventional smear microscopy and provides results within a matter of hours compared to weeks for solid culture, which is the current gold standart. The aim of this study was to compare the culture, microscopic smear and molecular method in the diagnosis of TB.
METHODS: Seven hundred ninety specimens belonging to clinically suspected cases of TB were studied retrospectively. The specimens were grouped as respiratory and non-respiratory and the groups were compared for mycobacterial detection assays. The culture and the molecular diagnostic GeneXpert MTB/RIF (GX) assay method were compared.
RESULTS: When culture was used as the reference standart, 32 (4.05%) specimens were positive for MTBC. Of the 32 culture positive clinical specimens 24 (3.03%) were respiratory and 8 (1.01%) were non-respiratory specimens. All 24 of the 24 respiratory specimens were positive by the GX test, Seven of the eight non-respiratory specimens positive for culture were positive by GX assay. Five of the seven hundred fifty-eight samples of culture negative were positive with GX assay. Sensitivity and specificity of GX were found to be 96.8 % and 99.3 %, respectively.
CONCLUSIONS: Molecular methods to acquire time in diagnosis as well as the increase in linearity gives a different perspective to the diagnosis of tuberculosis. The GX assay has a diagnostic utility for rapid diagnosis of TB. ©The Author 2018. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30229645      PMCID: PMC6194869     

Source DB:  PubMed          Journal:  Rev Esp Quimioter        ISSN: 0214-3429            Impact factor:   1.553


INTRODUCTION

Tuberculosis (TB) is a chronic disease caused by a type of Mycobacterium tuberculosis (MTB). TB is spread from person to person through the air. TB is the most common cause of death from infectious disease. In 2016, 6.3 million new cases of TB were reported (up from 6.1 million in 2015), equivalent to 61% of the estimated incidence of 10.4 million; the latest treatment outcome data show a global treatment success rate of 83%, similar to recent years . In 2016, a total of 12.417 TB cases were reported in Turkey, with an Incidence rate of 14: 100 000 patients with suspected TB [1]. Clinicians evaluate patients with suspected TB by medical history, physical examination , chest radiograph and checking up on patiens symptoms . TB is diagnosed by detecting of Mtb bacteria in a clinical specimen. Culture are remains the gold standard for laboratory confirmation of TB disease, and growing bacteria are required to perform drug-susceptibility testing. GeneXpert MTB/RIF (GX) (Cepheid, Sunnyvale, California, USA) assay is a new molecular test for TB which diagnoses Mtb by detecting the presence of Mtb bacteria, as well as testing for resistance to the drug rifampin [2,3]. In this study, we retrospectively evaluated the performance of solid and liquid culture media, acid-fast bacilli (AFB) testing and GeneXpert methods for respiratory and non-respiratory specimens for the diagnosis of TB.

MATERIAL AND METHODS

Clinical specimens. A retrospective study was conducted from January 2016 to June 2017 at the Ataturk Research and Traning Hospital, Department of Medical Microbiology , Izmir, Turkey. Respiratory and non-respiratory clinical specimens collected from patiens with suspected Mtb or nontuberculous mycobacterial (NTM) infection. A total of 790 specimens were assessed by solid (Löwenstein-Jensen), liquid (Bactec MGIT960) culture media and GX assay. Of the 790 specimens 483 were respiratory (sputum, broncho alveolar lavage, tracheal aspirate), and 307 were non-respiratory (urine, pleural fluid, ascites, tissue biopsy, abscess, bile fluid, cerebro spinal fluid) specimens. Laboratory methods. Clinical specimens were decontaminated using the N-acetyl-L-cysteine sodium hydroxide method (NALC-NaOH). After the centrifugation step, the sediment was resuspended in 1 to 1,5 of sterile phosphate buffer (pH 6.8). This suspension was used for inoculation of culture media. A smear of the processed sediment was prepared and examined for the presence of AFB. Liquid culture media based on fluorometric detection of growth. Mycobacteria Growth Indicator Tube (MGIT) tubes were inoculated with 0.5 ml of the processed specimen. The tubes were incubated in the MGIT 960 instrument at 37°C. Solid culture media, Lowenstein-Jensen (LJ) (Salubris , Turkey) was inoculated with 0.25 ml suspension processed for each specimen and incubated at 37°C. For tubes identified as positive, a smear of a sample from the tube was prepared for examination for AFB. All smears were stained by the Kinyoun method and examined with a light microscope. MTB strains isolated from culture were identified using the MGIT TBc ID method (MPT 64: Becton Dickinson, Sparks, Maryland, USA). After identification of MTB complex strains, drug susceptibility test (DST) was performed using MGIT SIRE (Becton Dickinson-Sparks, Maryland, USA) according to the manufacturer’s recommendations. Tests were performed using the final concentration (83 μg/ml) of streptomycin (STR), (8,3 μg/ml) isoniazid (INH), (83 μg/ml) rifampin (RIF), (415 μg/ml) etambutol (EMB). The GX for MTB/RIF assay procedure, the GX assay was performed following the manufacturer’s recommendations. Decontaminated samples were mixed with a sample reagent containing sodium hydroxide and isopropanol alcohol (GX reagent). Two milliliters of each sample was transferred to a test cartridge and inserted into the GX platform. Results were available 1 hour and 55 minutes later.

RESULTS

A total of 790 specimens with suspected TB infection which were assayed by liquid and solid culture, smear microscopy, GX method and conventional drug susceptibility testing. The results of culture, smear microscopy, and GX for all specimens are presented in table 1. Of the 790 specimens, 32 (4.05%) were culture positive for MTB. Of the 32 culture positive specimens, 24 (3.03%) were respiratory and 8 (1.01%) were non-respiratory.
Table 1

The results of culture, AFB and GX tests for all specimens

MethodAll specimens (n=790)Respiratory specimens (n=483)Non-respiratory specimens (n=307)
Culture (+)32248
AFB (+)17134
GX (+)31247
Culture (-)758459299
AFB (+)000
GX (+)541

AFB: acid-fast bacilli

The results of culture, AFB and GX tests for all specimens AFB: acid-fast bacilli Two specimens were culture-positive for non-tuberculosis mycobacteria (NTB). These two bacteria outside of MTBC were not detected by molecular methods. Because only MTBC types could be detected with the GX assay. Because of this, these two bacteria were considered out of the evaluation. According to culture results, the overall sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of GX and smear microscopy are shown in table 2.
Table 2

According to culture results, the overall sensitivity, specificity, PPV and NPV of GX

MethodSensitivitySpecifiticyPPVNPV
% (95% CI)% (95% CI)%%
AFB53 (34 - 70)100 (99 - 100)10098
GX96 (83-99)99 (98-99)8699
AFB (Respiratory)54 (32 - 74)100 (99 - 100)10097
AFB (Non-Respiratory)50 (15 - 84)100 (98 – 100)10098
GX (Respiratory)100 (87-100)99 (97-99)85100
GX (Non-Respiratory)87 (51-99)99 (98-99)8799

AFB: acid-fast bacilli, PPV: positive predictive value; NPV: negative predictive value; CI: confidence interval

According to culture results, the overall sensitivity, specificity, PPV and NPV of GX AFB: acid-fast bacilli, PPV: positive predictive value; NPV: negative predictive value; CI: confidence interval Thirty two Mtb isolates were tested for RMP resistance by the conventional drug susceptibility testing. Twenty nine (90.6 %) were found to be susceptible to RMP, while three (9.4 %) were resistant to RMP. All of the three samples identified as resistant by conventional methods were also found to be resistant by the GX method.

DISCUSSION

Classic laboratory techniques such as direct microscopy for the diagnosis of tuberculosis are far from being sensitive. Furthermore, cultures are time-consuming, they require biosafety precautions and need educated laboratory personnel [4]. Molecular techniques have substantially changed in the field of tuberculosis diagnosis and they have been proven to yield rapid results as well as being highly sensitive. Culture continues to be the gold standard for the diagnosis of TB, but isolation can take up to 6 weeks due to slow growth rate of the organism [5]. Smear microscopy to detect acid-fast bacilli in clinical specimens is a rapid and inexpensive test, although our study showed that microscopic detection sensitivity was 54 % in respiratory samples and 50 % in non-respiratory samples. However, despite having been proved to be a sensitive and rapid method when compared to the other methods evaluated in this study, GX proved to be more sensitive in both respiratory (100 vs. 54 %) and non-respiratory (87 vs. 50 %) specimens than smear testing. Ionniadis et al. Analyzed 80 respiratory and 41 non-respiratory samples, and reported the sensitivity, specifity, PPV, NPV of the GX system for respiratory and non-respiratory samples as 90%, 94%, 93%, 91%, 100%, 91%, 50%, 100% respectively. The GX system was found to be an advantageous technique for the identification of MTB , especially in smear-negative samples [6]. Bunsow et al. performed a study including 290 respiratory and 305 nonrespiratory. They reported the sensitivity and specifity, PPV, NPV values of GX as for respiratory specimens 97%, 98%, 95%, 99%, respectively and for non-respiratory specimens as 33%, 99%, 80%, 97% respectively. The values for respiratory samples were higher than the values of our study. The GX system was reported to be a rapid and it gave accurate results in identifiyng MTB particularly in smear positive respiratory specimens [7]. Zeka et al. performed a study including 253 respiratory and 176 non-respiratory specimens. They found the sensitivity and specificity, PPV, NPV values of GX for respiratory and non-respiratory specimens as 86%, 99%, 96%, 98% and 67%, 96%, 93%, 80% respectively. They reported that the GX assay was a rapid and useful technique in the identification of MTB [8]. Bilgin et al. performed a study including 243 respiratory, 684 non-respiratory specimens. The sensitivity, specificity, PPV, NPV values of GX for respiratory and non-respiratory samples were 100%, 98%, 87%, 100% and 71%, 98%, 71%, 98%, respectively. The GX method was reported to be a practical technique because it has a high sensitivity and gives rapid results for identification of MTB [9]. Wadwai et al. performed a study consisting of 547 non-respiratory specimens and they found the sensitivity and specificity of GX as 77% and 75%, respectively [10]. In another study, Tortellini et al. evaluated 1476 non-respiratory specimens and reported the sensitivity and specificity of the GX as 81% and 99%, respecticely [11]. Both studies concluded that the NALC-NaOH decontamination could affect the quality of the specimens reducing the sensitivity of the GX for MTB detection. The main purpose of this study was to assess the effectiveness of the GX assay in testing AFB-negative specimens collected from patients with clinical signs highly suggestive of active TB. The results of the culture, smear microscopy and GX assay in our study correlate with those reported by other studies when the effectiveness of the GX assay in detecting the presence of MTB bacilli in AFB negative specimens is considered. In our study, since culture was accepted as a standard, a total of five false positives were detected. A total of five samples were identified from four respiratory specimens from one non-respiratory specimen. Contamination in molecular methods is a consideration. In addition, live bacteria may not be taken as a specimen in treated patients. Since live and dead bacilli can not be discriminated by PCR methods, it is known that false positivity can be seen in patients with a history of MTB [9]. In our study, seventeen AFB positive samples was detected in culture-positive 32 samples. The sensitivity and specificity of AFB were found to be 53% and 100%, respectively. Similar results were found in the studies. In a study in Thailand, sensitivity and specificity of the sputum AFB smear and GeneXpertMTB/ RIF assay test were 48% and 84%, and 94% and 92%, respectively [12]. Although AFB is effective in eliminating tuberculosis-negative patients, it is less effective in detection than Genexpert. Thirty-two patients were diagnosed as TB in our hospital in this study period. We think that tuberculosis cases will increase due to immigration from Middle East (especially, Syria) and frequent use of immunosuppressant therapy. In conclusion, early diagnosis has great importance for the treatment of tuberculosis and the GX system is an easy and helpful tool for rapid and reliable results with high specifity and sensitivity.
  11 in total

1.  Evaluation of the GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens.

Authors:  Arzu N Zeka; Sezai Tasbakan; Cengiz Cavusoglu
Journal:  J Clin Microbiol       Date:  2011-09-28       Impact factor: 5.948

2.  Cepheid GeneXpert MTB/RIF assay for Mycobacterium tuberculosis detection and rifampin resistance identification in patients with substantial clinical indications of tuberculosis and smear-negative microscopy results.

Authors:  Panayotis Ioannidis; Dimitrios Papaventsis; Simona Karabela; Stavroula Nikolaou; Marina Panagi; Ekaterini Raftopoulou; Eythymia Konstantinidou; Ioanna Marinou; Sofia Kanavaki
Journal:  J Clin Microbiol       Date:  2011-06-15       Impact factor: 5.948

3.  Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?

Authors:  Viral Vadwai; Catharina Boehme; Pamela Nabeta; Anjali Shetty; David Alland; Camilla Rodrigues
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

4.  Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis.

Authors:  Enrico Tortoli; Cristina Russo; Claudio Piersimoni; Ester Mazzola; Paola Dal Monte; Michela Pascarella; Emanuele Borroni; Alessandra Mondo; Federica Piana; Claudio Scarparo; Luana Coltella; Giulia Lombardi; Daniela M Cirillo
Journal:  Eur Respir J       Date:  2012-01-12       Impact factor: 16.671

5.  Efficacy of BACTEC TB in the rapid confirmatory diagnosis of mycobacterial infections. A Lebanese tertiary care center experience.

Authors:  Lina Y Itani; Mohamad A Cherry; George F Araj
Journal:  J Med Liban       Date:  2005 Oct-Dec

6.  Evaluation of GeneXpert MTB/RIF for the detection of Mycobacterium tuberculosis and resistance to rifampin in clinical specimens.

Authors:  Eleonora Bunsow; María Jesús Ruiz-Serrano; Paula López Roa; Martha Kestler; Dario Garcia Viedma; Emilio Bouza
Journal:  J Infect       Date:  2013-12-01       Impact factor: 6.072

7.  Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology.

Authors:  Danica Helb; Martin Jones; Elizabeth Story; Catharina Boehme; Ellen Wallace; Ken Ho; JoAnn Kop; Michelle R Owens; Richard Rodgers; Padmapriya Banada; Hassan Safi; Robert Blakemore; N T Ngoc Lan; Edward C Jones-López; Michael Levi; Michele Burday; Irene Ayakaka; Roy D Mugerwa; Bill McMillan; Emily Winn-Deen; Lee Christel; Peter Dailey; Mark D Perkins; David H Persing; David Alland
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

8.  COMPARISON OF GeneXpert MTB/RIF ASSAY WITH CONVENTIONAL AFB SMEAR FOR DIAGNOSIS OF PULMONARY TUBERCULOSIS IN NORTHEASTERN THAILAND.

Authors:  Wipa Reechaipichitkul; Tanapong Suleesathira; Prajaub Chaimanee
Journal:  Southeast Asian J Trop Med Public Health       Date:  2017-03       Impact factor: 0.267

9.  Comparison of a real-time polymerase chain reaction-based system and Erlich-Ziehl-Neelsen method with culture in the identification of Mycobacterium tuberculosis.

Authors:  Kemal Bilgin; Keramettin Yanik; Adil Karadağ; Hakan Odabaşi; Hakan Taş; Murat Günaydin
Journal:  Turk J Med Sci       Date:  2016-01-05       Impact factor: 0.973

10.  Evaluation of laboratory diagnosis for cutaneous tuberculosis.

Authors:  Ilhan Afsar; Fatma Sule Afsar
Journal:  Indian J Pathol Microbiol       Date:  2016 Jul-Sep       Impact factor: 0.740

View more
  12 in total

1.  Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Mandy Yao; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2021-01-15

2.  Evaluating the efficacy of stool sample on Xpert MTB/RIF Ultra and its comparison with other sample types by meta-analysis for TB diagnostics.

Authors:  Vishal Sharma; Anoop Singh; Mohita Gaur; Deepti Rawat; Anjali Yadav; Chanchal Kumar; Mandira Varma-Basil; Sheelu Lohiya; Vishal Khanna; Ashwani Khanna; Anil Chaudhry; Yogendra Singh; Richa Misra
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-05-04       Impact factor: 3.267

3.  Differentiating between drug-sensitive and drug-resistant tuberculosis with machine learning for clinical and radiological features.

Authors:  Feng Yang; Hang Yu; Karthik Kantipudi; Manohar Karki; Yasmin M Kassim; Alex Rosenthal; Darrell E Hurt; Ziv Yaniv; Stefan Jaeger
Journal:  Quant Imaging Med Surg       Date:  2022-01

4.  Mycobacterium tuberculosis antigen-specific T-cell responses in smear-negative pulmonary tuberculosis patients.

Authors:  Ahmed Esmael; Tamrat Abebe; Adane Mihret; Daniel Mussa; Sebsib Neway; Joel Ernst; Jyothi Rengarajan; Liya Wassie; Rawleigh Howe
Journal:  Clin Exp Immunol       Date:  2022-07-22       Impact factor: 5.732

5.  Nanoparticle-Based Biosensing Assay for Universally Accessible Low-Cost TB Detection with Comparable Sensitivity as Culture.

Authors:  Ruben Kenny Briceno; Shane Ryan Sergent; Santiago Moises Benites; Evangelyn C Alocilja
Journal:  Diagnostics (Basel)       Date:  2019-12-13

6.  A novel, rapid (within hours) culture-free diagnostic method for detecting live Mycobacterium tuberculosis with high sensitivity.

Authors:  Wen-Hung Wang; Rikiya Takeuchi; Shu-Huei Jain; Yong-Huang Jiang; Sonoko Watanuki; Yoshiharu Ohtaki; Kazunari Nakaishi; Satoshi Watabe; Po-Liang Lu; Etsuro Ito
Journal:  EBioMedicine       Date:  2020-09-16       Impact factor: 8.143

Review 7.  Sarcoidosis: Pitfalls and Challenging Mimickers.

Authors:  Naureen Narula; Michael Iannuzzi
Journal:  Front Med (Lausanne)       Date:  2021-01-11

8.  Abdominal cyst of unclear aetiology: gastrointestinal stromal tumour or reactivation of abdominal tuberculosis.

Authors:  Damini Saxena; Robert A Duncan; Robert R Faust; Anthony Campagna
Journal:  BMJ Case Rep       Date:  2022-01-06

9.  Clinical Features and Risk Factors for Active Tuberculosis in Takayasu Arteritis: A Single-Center Case-Control Study.

Authors:  Jiawei Zhou; Ruoyu Ji; Rui Zhu; Jingya Zhou; Jing Li; Xinping Tian; Yuexin Chen; Yuehong Zheng
Journal:  Front Immunol       Date:  2021-10-29       Impact factor: 7.561

Review 10.  Sensor-as-a-Service: Convergence of Sensor Analytic Point Solutions (SNAPS) and Pay-A-Penny-Per-Use (PAPPU) Paradigm as a Catalyst for Democratization of Healthcare in Underserved Communities.

Authors:  Victoria Morgan; Lisseth Casso-Hartmann; David Bahamon-Pinzon; Kelli McCourt; Robert G Hjort; Sahar Bahramzadeh; Irene Velez-Torres; Eric McLamore; Carmen Gomes; Evangelyn C Alocilja; Nirajan Bhusal; Sunaina Shrestha; Nisha Pote; Ruben Kenny Briceno; Shoumen Palit Austin Datta; Diana C Vanegas
Journal:  Diagnostics (Basel)       Date:  2020-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.